RPG Life Sciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of RPG Life Sciences Limited generated cash of $943,600,000, which is more than the previous year. Cash used in financing activities reached the amount of -$203,100,000 last year. Net change in cash is therefore -$51,000,000.
Cash Flow
| 2010 | 205.65M | -39.72M | -160.11M |
|---|---|---|---|
| 2011 | 144.21M | -128.28M | -19.15M |
| 2012 | 157.5M | -78.3M | -78.4M |
| 2016 | 328.1M | -151.7M | -175.7M |
| 2018 | 146.8M | -155.4M | 1.1M |
| 2020 | 501.7M | -107M | -393M |
| 2021 | 582.7M | -79.6M | -104.9M |
| 2023 | 908.2M | -1.05B | -171.2M |
| 2024 | 943.6M | -791.5M | -203.1M |
RPGLIFE.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 248.2M | 569.4M | 5.4M | 3.7M | 8.6M | 2.5M | 4.8M | 8.00M | 2.19M |
Operating activities | |||||||||
Net income | 876.6M | 916.8M | 535.8M | 364.5M | 203.6M | 116.2M | 8.5M | 127.12M | 107.96M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 170.7M | 155M | 164.7M | 163.6M | 143.4M | 101.5M | 102.2M | 95.20M | 91.82M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -142.3M | -54M | 62.2M | -235.3M | -284.6M | 31.5M | 0 | 0 | 0 |
Inventories | -59.5M | -120.6M | -117.2M | -55.7M | -79.1M | -45.4M | -26.8M | -114.10M | -7.94M |
Accounts payable | 63.3M | 192.6M | 31.2M | 193.3M | 236.1M | 123.1M | 0 | 0 | 0 |
Cash generated by operating activities | 943.6M | 908.2M | 582.7M | 501.7M | 146.8M | 328.1M | 157.5M | 144.21M | 205.65M |
Investing activities | |||||||||
Purchases Of Investments | -445.1M | -569.9M | -2.3M | -1.7M | 0 | -800K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -692.3M | -327.3M | -85.1M | -107.4M | -154.8M | -153.7M | -86.7M | -112.79M | -55.04M |
Acquisitions Net | 0 | 800K | 500K | 400K | 200K | 1.7M | 0 | 0 | 0 |
Cash generated by investing activities | -791.5M | -1.05B | -79.6M | -107M | -155.4M | -151.7M | -78.3M | -128.28M | -39.72M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.47M | 12.44M |
Payments for dividends | -198.5M | -158.8M | 0 | -127.7M | -55.3M | -47.5M | -26.1M | -21.37M | -14.73M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -100K | -2.8M | -44.7M | -241.3M | 94.2M | -103.5M | -40.7M | -72.08M | -279.96M |
Cash used in financing activities | -203.1M | -171.2M | -104.9M | -393M | 1.1M | -175.7M | -78.4M | -19.15M | -160.11M |
Net Change In Cash | -51M | -321.2M | 398.2M | 1.7M | -7.5M | 600K | 800K | -3.23M | 5.81M |
Cash at end of period | 197.2M | 248.2M | 403.6M | 5.4M | 1.1M | 3.1M | 5.6M | 4.77M | 8.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |